Share:
  • Title:Tony Mok, The Chinese University of Hong Kong, Shatin, China
  • Duration: 5:28
  • Plays: 830 views
  • Published: 10 years ago
Download MP3
Download MP4


Simillar Videos

ASCO23 - LBA4: SWOG S1826, Nivolumab(N)-AVD vs. Brentuximab Vedotin(BV)-AVD in Advanced Stage (A...▶️ 10:42
Asco23 - Lba4: Swog S1826, Nivolumab(n)-avd Vs. Brentuximab Vedotin(bv)-avd In Advanced Stage (a... 830 views • 1 year ago
ASH23: Daratumumab (DARA) + Bortezomib, Lenalidomide, & Dexamethasone (VRd) vs Vrd Alone: Primar...▶️ 9:02
Ash23: Daratumumab (dara) + Bortezomib, Lenalidomide, & Dexamethasone (vrd) Vs Vrd Alone: Primar... 830 views • 10 months ago
ASH 2022: Consolidation Therapy with Blinatumomab Improves OS in Newly Diagnosed Adult B-Lineage...▶️ 5:24
Ash 2022: Consolidation Therapy With Blinatumomab Improves Os In Newly Diagnosed Adult B-lineage... 830 views • 1 year ago
ASH23: Revumenib Monotherapy in RR KMT2Ar Acute Leukemia: Efficacy & Safety Results from the Piv...▶️ 7:20
Ash23: Revumenib Monotherapy In Rr Kmt2ar Acute Leukemia: Efficacy & Safety Results From The Piv... 830 views • 10 months ago
Oncoletter Live Stream▶️ 0:21
Oncoletter Live Stream 830 views • Streamed 4 years ago